Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Janux Therapeutics Inc shares valued at $4,988,643 were purchased by Avalon Ventures XI, L.P. on Nov 13 ’23. At $5.87 per share, Avalon Ventures XI, L.P. acquired 849,854 shares. The insider’s holdings grew to 849,854 shares worth approximately $40.97 million following the completion of this transaction.
Also, Reardon Tighe purchased 849,854 shares, netting a total of over 4,988,643 in proceeds. Following the buying of shares at $5.87 each, the insider now holds 849,854 shares.
Before that, Lichter Jay had added 849,854 shares to its account. In a trade valued at $4,988,643, the Director bought Janux Therapeutics Inc shares for $5.87 each. Upon closing the transaction, the insider’s holdings increased to 849,854 shares, worth approximately $40.97 million.
As published in their initiating research note from BTIG Research on March 21, 2024, Janux Therapeutics Inc [JANX] has been a Buy and the price target has been revised to $62. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid March. As of April 06, 2023, Wedbush has initiated its “an Outperform” rating for JANX. Earlier on November 14, 2022, William Blair initiated its rating. Their recommendation was “an Outperform” for JANX stock.
Analyzing JANX Stock Performance
During the last five days, there has been a surge of approximately 0.52%. Over the course of the year, Janux Therapeutics Inc shares have jumped approximately 349.30%. Shares of the company reached a 52-week high of $58.69 on 02/28/24 and a 52-week low of $7.79 on 02/05/24. A 50-day SMA is recorded $37.02, while a 200-day SMA reached $16.70. Nevertheless, trading volume fell to 0.58 million shares from 0.71 million shares the previous day.
Support And Resistance Levels for Janux Therapeutics Inc (JANX)
According to the 24-hour chart, there is a support level at 46.47, which, if violated, would cause prices to drop to 44.72. In the upper region, resistance lies at 50.01. The next price resistance is at 51.80. RSI (Relative Strength Index) is 62.76 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.11, which suggests the price will increase in the coming days. Percent R is at 37.25%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
